Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Technical brief | 22 January 2016 138th WHO EB - Global shortages of medicines, and the safety and accessibility of chidren’s medication. Agenda item 10-5 VACCINES Download EB138 shortages briefing Agenda item 10-5.pdf